TAFA4 and cervical carcinoma: Smaller series of cervical carcinomas were also evaluated for FAM19A4 alone, EPB41L3 (with and without viral markers), CADM1/MAL/miR124‐2, ASTN1/DLX1/ITGA4/RXFP3/SOX17/ZNF671 and POU4F3, all showing detection rates well over 90%.27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40